Correlation Between Athira Pharma and Bellus Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Athira Pharma and Bellus Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Athira Pharma and Bellus Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Athira Pharma and Bellus Health, you can compare the effects of market volatilities on Athira Pharma and Bellus Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Athira Pharma with a short position of Bellus Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Athira Pharma and Bellus Health.

Diversification Opportunities for Athira Pharma and Bellus Health

  Correlation Coefficient

Very weak diversification

The 3 months correlation between Athira and Bellus is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Athira Pharma and Bellus Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellus Health and Athira Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Athira Pharma are associated (or correlated) with Bellus Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellus Health has no effect on the direction of Athira Pharma i.e., Athira Pharma and Bellus Health go up and down completely randomly.

Pair Corralation between Athira Pharma and Bellus Health

Given the investment horizon of 90 days Athira Pharma is expected to under-perform the Bellus Health. In addition to that, Athira Pharma is 1.11 times more volatile than Bellus Health. It trades about -0.03 of its total potential returns per unit of risk. Bellus Health is currently generating about 0.08 per unit of volatility. If you would invest  245.00  in Bellus Health on July 5, 2022 and sell it today you would earn a total of  808.00  from holding Bellus Health or generate 329.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
ValuesDaily Returns

Athira Pharma  vs.  Bellus Health

 Performance (%) 
Athira Pharma 
Athira Performance
0 of 100
Over the last 90 days Athira Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Athira Price Channel

Bellus Health 
Bellus Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bellus Health are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Bellus Health may actually be approaching a critical reversion point that can send shares even higher in November 2022.

Bellus Price Channel

Athira Pharma and Bellus Health Volatility Contrast

   Predicted Return Density   

Pair Trading with Athira Pharma and Bellus Health

The main advantage of trading using opposite Athira Pharma and Bellus Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Athira Pharma position performs unexpectedly, Bellus Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will offset losses from the drop in Bellus Health's long position.
Athira Pharma vs. Ase Industrial Holding
Athira Pharma vs. Asml Holdings NY
Athira Pharma vs. Lam Research Corp
Athira Pharma vs. Microchip Technology
The idea behind Athira Pharma and Bellus Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Bellus Health vs. Comcast Corp A
Bellus Health vs. Pt Telekomunik Ind
Bellus Health vs. Telstra Corp
Bellus Health vs. America Movil SAB
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum